newsfilter
← Latest News
GlobeNewswire·

Inhibikase Announces Expansion of Senior Leadership Team

--- Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development --- --- John Adams, PhD Appointed Chief Scientific Officer --- --- Vince Aurentz to join Inhibikase Board of Directors ---